Search

Author/Creator Goliaei, Ardeshir

1. Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic‐Pharmacodynamic Modeling Approaches. (17th November 2020)

Authors:
Chaudhury, Anwesha; Zhu, Xu; Chu, Lulu; Goliaei, Ardeshir; June, Carl H.; Kearns, Jeffrey D.; Stein, Andrew M.
Other Names:
Arya Vikram guestEditor.; Venkatakrishnan Karthik guestEditor.
Journal:
Journal of clinical pharmacology
Issue:
Volume 60(2020)Supplement 1
Page Start:
S147
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Multiscale Model Identifies Improved Schedule for Treatment of Acute Myeloid Leukemia In Vitro With the Mcl‐1 Inhibitor AZD5991. (17th September 2020)

Authors:
Goliaei, Ardeshir; Woods, Haley A.; Tron, Adriana E.; Belmonte, Matthew A.; Secrist, J. Paul; Ferguson, Douglas; Drew, Lisa; Fretland, Adrian J.; Aldridge, Bree B.; Gibbons, Francis D.
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 9:Number 10(2020)
Page Start:
561
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Subcellular localization of Rap1 GTPase activator CalDAG‐GEFI is orchestrated by interaction of its atypical C1 domain with membrane phosphoinositides. (30th December 2019)

Authors:
Sarker, Muzaddid; Goliaei, Ardeshir; Golesi, Florence; Poggi, Marjorie; Cook, Aaron A.; Khan, Mohammad A. I.; Temple, Brenda R.; Stefanini, Lucia; Canault, Matthias; Bergmeier, Wolfgang; Campbell, Sharon L.
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 18:Number 3(2020)
Page Start:
693
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗